Aoxin Q & M 1D4

SGD 0.145 +0.00% +0.00 Updated 16 Nov 2026, 09:05 SGT

Company profile

The business, the people and the ownership behind Aoxin Q & M.

Business overview

About the company

Aoxin Q & M Dental Group provides private dental healthcare services in Liaoning Province, China. It operates dental hospitals and polyclinics across several cities, including Shenyang, Huludao, Panjin, Gaizhou, Zhuanghe, Jinzhou and Dalian.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-10. PDF p. 4

Listed security

Company & listing

Full Company Name
AOXIN Q & M DENTAL GRP LIMITED
Trading Currency
SGD
Website
www.aoxinqm.com.sg
Listing
Listed on 26 April 2017 on Catalist
ISIN Code
SG1DF9000000

Board & management

Leadership

Mr. Chua Ser Miang

Non-Executive Chairman and Independent Director

Board of Directors

Professor Chew Chong Yin

Independent Director

Board of Directors

Mr. Lin Ming Khin

Independent Director

Board of Directors

Mr. Chong Eng Wee

Independent Director

Board of Directors

Ms. Ng Sook Hwa

Non-Executive and Non-Independent Director

Board of Directors

Dr. Ng Chin Siau

Non-Executive and Non-Independent Director

Board of Directors

Roles listed in ANNUAL REPORT 2025; current appointments are not independently verified.

Holdings

Ownership

Q & M Dental Group (Singapore) Limited

Direct: 538,579,592 shares (52.64%); Deemed: – (–)

Substantial shareholders; % based on 1,023,044,096 shares

Quan Min Holdings Pte. Ltd.

Direct: 5,125,600 shares (0.50%); Deemed: 538,579,592 shares (52.64%)

Substantial shareholders; % based on 1,023,044,096 shares

Dr. Ng Chin Siau

Direct: 326,600 shares (0.03%); Deemed: 543,725,192 shares (53.15%)

Substantial shareholders; % based on 1,023,044,096 shares

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-20 · PDF p. 105

Registered holderInterestShares / unitsSource
Q & M DENTAL GROUP (SINGAPORE) LIMITED538,579,592 shares (52.64%)PDF p. 1052026-03-20
DBS NOMINEES PTE LTD65,342,164 shares (6.39%)PDF p. 1052026-03-20
ONG SIEW HWA (WANG XIUHUA)46,327,318 shares (4.53%)PDF p. 1052026-03-20
LIM AND TAN SECURITIES PTE LTD43,251,600 shares (4.23%)PDF p. 1052026-03-20
MAYBANK SECURITIES PTE. LTD.28,093,500 shares (2.75%)PDF p. 1052026-03-20
ABN AMRO CLEARING BANK N.V.24,125,600 shares (2.36%)PDF p. 1052026-03-20
PHILLIP SECURITIES PTE LTD23,332,726 shares (2.28%)PDF p. 1052026-03-20
TIGER BROKERS (SINGAPORE) PTE. LTD.21,562,100 shares (2.11%)PDF p. 1052026-03-20
HEALTH FIELD ENTERPRISES LIMITED21,428,229 shares (2.09%)PDF p. 1052026-03-20
CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD.17,528,000 shares (1.71%)PDF p. 1052026-03-20
LIM KUO KAE17,350,000 shares (1.70%)PDF p. 1052026-03-20
OCBC SECURITIES PRIVATE LTD15,805,840 shares (1.54%)PDF p. 1052026-03-20
ONG GIM LOO15,800,000 shares (1.54%)PDF p. 1052026-03-20
LIM YONG LUY11,270,400 shares (1.10%)PDF p. 1052026-03-20
FINEST INTERNATIONAL LIMITED10,516,320 shares (1.03%)PDF p. 1052026-03-20
LOW CHUI HENG10,300,000 shares (1.01%)PDF p. 1052026-03-20
UOB KAY HIAN PTE LTD9,591,913 shares (0.94%)PDF p. 1052026-03-20
MOUNTAIN LIMITED7,265,605 shares (0.71%)PDF p. 1052026-03-20
MOOMOO FINANCIAL SINGAPORE PTE. LTD.6,077,700 shares (0.59%)PDF p. 1052026-03-20
EXCELLENT WARSHIP INTERNATIONAL LIMITED5,502,969 shares (0.54%)PDF p. 1052026-03-20

Group structure

Main operating subsidiaries

CompanyMarketOwnership interest
Shenyang Xinao Hospital Management Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Aoxin Q & M Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Heping Q & M Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Huludao City Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Huludao Aoxin Q & M Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Quanxin Medical Equipment Leasing Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Panjin Jinsai Q & M Stomatology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Panjin Jingcheng Q & M Stomatology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Gaizhou City Aoxin Q & M Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Zhuanghe City Aoxin Dawei Dental Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Panjin Aoxin Quanmin Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Maotai Q & M Medical Equipment Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Shengtai Shenmao Trading Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Qingaomei Oral Restorative Technology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Qicheng (Shenyang) Digital Intelligent Technology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Quanao Medical Investment Management Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 99% (2025); 99% (2024); held through subsidiaries
Shenyang Shenhe Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Dalian Aoxin Quanmin Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Huludao Longgang District Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Jinzhou Aoxin Youxin Dental Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries
Shenyang Xinchuang Medical Technology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
DR. BAI YI GENERAL MANAGER PDF p. 13
MR. CUI GUOAN CHIEF OPERATING OFFICER CUM DEPUTY CHIEF EXECUTIVE OFFICER PDF p. 13
DR. JIA DAWEI DEPUTY CHIEF EXECUTIVE OFFICER PDF p. 13
MS. WANG JIE DEPUTY CHIEF EXECUTIVE OFFICER PDF p. 13
MR. YUE WEI DEPUTY CHIEF EXECUTIVE OFFICER PDF p. 14
MR. LOO KEAT CHOON FINANCIAL CONTROLLER PDF p. 14
MR. HUANG ZHENXING DEPUTY GENERAL MANAGER PDF p. 14
MR. ZHANG DONGWEI DEPUTY GENERAL MANAGER (FINANCE) PDF p. 14

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Class of shares Ordinary Shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105
Voting rights One vote per ordinary share As at 20 March 2026 · As at 2026-03-20 PDF p. 105
Number of issued and paid-up shares 1,023,044,096 shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105

Treasury shares

ItemValuePeriod / scopeSource
Number of treasury shares NIL As at 20 March 2026 · As at 2026-03-20 PDF p. 105
Number of subsidiary holding NIL As at 20 March 2026 · As at 2026-03-20 PDF p. 105

Shareholding distribution

ItemValuePeriod / scopeSource
Total 581 shareholders As at 20 March 2026; total shareholders; 100.00% · As at 2026-03-20 PDF p. 105
1 – 99 1 holder; 0.17% of holders; 50 shares; 0.00% of shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105
100 – 1,000 157 holders; 27.02% of holders; 145,735 shares; 0.01% of shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105
1,001 – 10,000 131 holders; 22.55% of holders; 683,100 shares; 0.07% of shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105
10,001 – 1,000,000 249 holders; 42.86% of holders; 36,221,008 shares; 3.54% of shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105
1,000,001 and above 43 holders; 7.40% of holders; 985,994,203 shares; 96.38% of shares As at 20 March 2026 · As at 2026-03-20 PDF p. 105

Free float

ItemValuePeriod / scopeSource
Shareholding held in the hands of the public approximately 46.80% As at 20 March 2026 · As at 2026-03-20 PDF p. 106
Rule 723 compliance Accordingly, Rule 723 of the Catalist Rules, is complied with. As at 20 March 2026 · As at 2026-03-20 PDF p. 106

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Singapore Dental Cadcam Laboratory Pte. Ltd. S$716,000* FY2025 Rule 907 IPT; revenue from laboratory services segment; subsidiary of Q & M Dental Group (Singapore) Limited, a controlling shareholder PDF p. 41
Singapore Dental Cadcam Laboratory Pte. Ltd. S$2,000* FY2025 Rule 907 IPT; management fee income PDF p. 41
Singapore Dental Cadcam Laboratory Pte. Ltd. S$156,000* FY2025 Rule 907 IPT; other expenses PDF p. 41
Revenue from laboratory services 3,939 RMB'000 Group, 2025 (comparative 2024: 2,588) PDF p. 73
Management fee expenses (660) RMB'000 Group, 2025 (comparative 2024: (467)) PDF p. 73

Director remuneration

ItemValuePeriod / scopeSource
Salaries and other short-term employee benefits 4,355 RMB'000 Group, 2025 (comparative 2024: 4,268) PDF p. 73
Directors' fees total S$295,750 FY2025 total Directors' fees PDF p. 33
Mr. Chua Ser Miang 85,000 S$ FY2025 total remuneration, S$ (all directors table; fees only) PDF p. 33
aggregate remuneration paid to all the key management personnel approximately S$457,000 FY2025, eight key management personnel who are not Directors or Group CEO PDF p. 33

Subsequent events

ItemValuePeriod / scopeSource
Placement agreements up to 84,000,000 Placement Shares at an issue price of S$0.1566 for each Placement Share Events after reporting period, Note 33(a) PDF p. 103
Performance shares 45,000,000 performance shares will be awarded to a selected group of high-performing employees Events after reporting period, Note 33(b) · As at 2026-03-02 PDF p. 103
Cessation of operation of Panjin Aoxin Quanmin Stomatology Hospital Co., Ltd the Board of Directors approved the closure of Panjin Hospital upon the expiry of its lease in April 2026 Events after reporting period, Note 33(c) · As at 2026-03-23 PDF p. 104
Memorandum of understanding non-binding MOU in relation to the proposed acquisition of 100% equity interest in a dental group based in central of PRC Events after reporting period, Note 33(d) · As at 2026-03-25 PDF p. 104

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Source: ANNUAL REPORT 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
05 May 2011
Email
[email protected]
Telephone
(65) 6236 3333
Fax
(65) 6779 5104
Registered Office
9 Raffles Place
#26-01 Republic Plaza
Singapore 048619
Secretary
Tong Shan Helen
Registrar / Transfer Agent
TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address
9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors
RSM SG ASSURANCE LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks